NEW YORK (GenomeWeb News) – PerkinElmer today said that it has entered into a drug discovery research collaboration with Sangmyung University in Korea, which will use the firm's AequoScreen assay technology for G-protein coupled receptor research.
PerkinElmer said that the AequoScreen cell-based assays are used to detect GPCR activation and provide advantages over conventional fluorescence-based dyes, such as fewer false positives, simpler protocol, and increased assay windows.
The firm said that Sangmyung will use the assays as part of its efforts to establish an academic GPCR screening facility in collaboration with Korea Chemical Bank, which has a repository library of more than 100,000 small molecule compounds. The assays will be used as part of nationwide GPCR screening campaigns and drug discovery programs, said PerkinElmer.
Financial terms of the alliance were not disclosed.